ES2194308T3 - Utilizacion de sustancias con una actividad de oxitocina en la preparacion de medicamentos para la curacion de heridas. - Google Patents

Utilizacion de sustancias con una actividad de oxitocina en la preparacion de medicamentos para la curacion de heridas.

Info

Publication number
ES2194308T3
ES2194308T3 ES98912862T ES98912862T ES2194308T3 ES 2194308 T3 ES2194308 T3 ES 2194308T3 ES 98912862 T ES98912862 T ES 98912862T ES 98912862 T ES98912862 T ES 98912862T ES 2194308 T3 ES2194308 T3 ES 2194308T3
Authority
ES
Spain
Prior art keywords
substances
preparation
activity
wound healing
oxitocine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98912862T
Other languages
English (en)
Inventor
Thomas Lundeberg
Moberg Kerstin Uvnaes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EntreTech Medical AB
Original Assignee
EntreTech Medical AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EntreTech Medical AB filed Critical EntreTech Medical AB
Application granted granted Critical
Publication of ES2194308T3 publication Critical patent/ES2194308T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La invención se refiere a sustancias que tienen una actividad de oxitocina y que pueden utilizarse en la preparación de una composición farmacéutica destinada al tratamiento o a la profilaxis de heridas tales como heridas crónicas. El efecto de cicatrización de una herida puede reforzarse o prolongarse por combinación de oxitocina y estrógeno.
ES98912862T 1997-03-27 1998-03-26 Utilizacion de sustancias con una actividad de oxitocina en la preparacion de medicamentos para la curacion de heridas. Expired - Lifetime ES2194308T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9701162A SE9701162D0 (sv) 1997-03-27 1997-03-27 New use II

Publications (1)

Publication Number Publication Date
ES2194308T3 true ES2194308T3 (es) 2003-11-16

Family

ID=20406369

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98912862T Expired - Lifetime ES2194308T3 (es) 1997-03-27 1998-03-26 Utilizacion de sustancias con una actividad de oxitocina en la preparacion de medicamentos para la curacion de heridas.

Country Status (10)

Country Link
US (1) US6262021B1 (es)
EP (1) EP1003542B1 (es)
JP (1) JP2001519786A (es)
CN (1) CN1251530A (es)
AT (1) ATE232393T1 (es)
AU (1) AU749479B2 (es)
DE (1) DE69811371T2 (es)
ES (1) ES2194308T3 (es)
SE (1) SE9701162D0 (es)
WO (1) WO1998043661A1 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080004224A1 (en) * 1994-05-04 2008-01-03 Hlavka Joseph J Dermatological uses of tri-, tetra-, penta-, and polypeptides
SE9701184D0 (sv) * 1997-04-01 1997-04-01 Karolinska Innovations Ab Substanser för att åstadkomma preferens och skapa acceptans
SE9803272D0 (sv) * 1998-09-25 1998-09-25 Kerstin Uvnaes Moberg A drug for cell regeneration
SE0001440D0 (sv) * 2000-04-18 2000-04-18 Entretech Medical Ab A drug against climacteric disorders
SE0100684D0 (sv) * 2001-02-28 2001-02-28 Kerstin Uvnaes Moberg New subject-matter
KR100441167B1 (ko) * 2001-12-27 2004-07-21 씨제이 주식회사 마이크로에멀젼 예비 농축액 조성물
EP1468690B1 (en) * 2003-03-27 2008-10-08 Pantarhei Bioscience B.V. Use of estrogens for the treatment of infertility in male mammals
JO2937B1 (en) 2004-08-11 2016-03-15 فيرينغ.بي.في Tight muscles of the peptide vascular tensioner receptor
JP4747364B2 (ja) * 2005-04-04 2011-08-17 独立行政法人産業技術総合研究所 紫外線皮膚炎抑止剤およびアトピー性皮膚炎抑止剤
US7660413B2 (en) * 2005-04-08 2010-02-09 Shahram Partovi Secure digital couriering system and method
JP5276982B2 (ja) 2005-08-26 2013-08-28 ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ オキシトシンの投与による頭痛の処置のための方法
US8883965B2 (en) * 2006-02-10 2014-11-11 Ferring B.V. Compounds
US20080004223A1 (en) * 2006-05-17 2008-01-03 Hlavka Joseph J Dermatological uses of the tripeptide melanocyte stimulating inhibitory factor (mif)
EP2175874A2 (en) * 2007-08-14 2010-04-21 Ferring B.V. Use of peptidic vasopressin receptor agonists
JP2010538991A (ja) * 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト 治療剤としてのｓｆｌｌｒ−ｏｈおよびムラミルジペプチドの使用
US20100204107A1 (en) * 2007-09-11 2010-08-12 Dorian Bevec Use of urodilatin as a therapeutic agent
WO2009033820A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
WO2009033667A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
AU2008303928A1 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of NF-KAPPAB inhibitor SN50 and optionally angiotensin III as therapeutic agents in the treatment of EG HBV infection
PL2205623T3 (pl) * 2007-10-29 2016-09-30 Ochronne tetrapeptydy do pielęgnacji skóry
WO2011140608A1 (en) * 2010-05-14 2011-11-17 Keating Charlotte L Neuropsychopharmacological treatment regimes for treating psychological disorders
WO2011160055A2 (en) * 2010-06-18 2011-12-22 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Hair follicle neogenesis
WO2012016229A2 (en) 2010-07-30 2012-02-02 The Regents Of The University Of California Oxytocin treatment to improve memory and modify blood glucose
SE536091C2 (sv) 2011-04-14 2013-04-30 Pep Tonic Medical Ab Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US20130040923A1 (en) 2011-05-13 2013-02-14 Trimel Pharmaceuticals Corporation Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
DE102011118016A1 (de) * 2011-10-26 2013-05-02 Henkel Ag & Co. Kgaa Kosmetische Mittel enthaltend Oxytocin und Riechstoffe
US9387183B2 (en) 2011-12-28 2016-07-12 Kuwait University Method of treating diabetes-related impaired wound healing
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
US10478526B2 (en) 2013-05-03 2019-11-19 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Skin substitutes and methods for hair follicle neogenesis
CA2949173A1 (en) 2014-06-03 2015-12-10 Caterina Bissantz Peptides as oxytocin agonists
PL3242676T3 (pl) 2015-01-07 2024-07-15 Tonix Pharma Limited Preparaty oksytocyny zawierające magnez i sposoby ich stosowania
HRP20250215T1 (hr) 2016-04-12 2025-06-20 Tonix Pharma Limited Formulacije oksitocina koje sadrže magnezij i postupci upotrebe
CN107456570A (zh) * 2017-07-31 2017-12-12 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 催产素在促进缺血超长随意皮瓣存活中的作用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3274060A (en) * 1962-05-23 1966-09-20 Armour Pharma Treatment of multiple sclerosis with oxytocin
NL129421C (es) * 1963-08-30 1900-01-01
WO1988005661A1 (en) 1987-01-30 1988-08-11 Biomed Research Consultants, Limited Vasopressin-based pharmaceutical compositions
US5175144A (en) * 1988-11-29 1992-12-29 The Johns Hopkins University Method of retarding the progression of chronic renal failure
SE9701161D0 (sv) * 1997-03-27 1997-03-27 Karolinska Innovations Ab New use I

Also Published As

Publication number Publication date
ATE232393T1 (de) 2003-02-15
CN1251530A (zh) 2000-04-26
DE69811371T2 (de) 2003-12-18
JP2001519786A (ja) 2001-10-23
EP1003542A1 (en) 2000-05-31
AU6755098A (en) 1998-10-22
DE69811371D1 (de) 2003-03-20
US6262021B1 (en) 2001-07-17
WO1998043661A1 (en) 1998-10-08
AU749479B2 (en) 2002-06-27
EP1003542B1 (en) 2003-02-12
SE9701162D0 (sv) 1997-03-27

Similar Documents

Publication Publication Date Title
SE9701162D0 (sv) New use II
NO20022998D0 (no) Farmasöytiske preparater som tilveiebringer foröket konsentrasjon av medikament
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
SE9701161D0 (sv) New use I
NO20004282D0 (no) Matriksproteinpreparater for sÕrheling
ATE243196T1 (de) Piperidine und pyrrolidine
ES2181165T3 (es) Uso de un peptido asociado a la latencia para la preparacion de un medicamento para aumentar la curacion de heridas.
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
DE59902006D1 (de) Wirkstoffhaltige aromatische copolyester
NO934706L (no) Substituerte 4-fenyl-pyridoner og 4-fenyl-2-alkoksypyridiner
DE69633396D1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
ES2080037T1 (es) Medicamento de uso topico con actividad cicatrizante.
AU2002343046A1 (en) Medical dressings
TR199802351T2 (xx) Topikal kullanım için bir veya birden fazla lokal anestezik ve anti-vajinit maddeler ihtiva eden anti-vajinit bileşimi.
ES2174533T3 (es) Uso de una mezcla de un diol y un acido alfa-hidroxi para el tratamiento de enfermedades de la piel hiperqueratoticas.
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
ATE405276T1 (de) Pharmazeutische gel-zusammensetzung
CO5011042A1 (es) Uso de una oxazolidinona para la fabricacion de un medicamento para administracion topica
GB2368523A (en) Solid wound healing formulations containing fibronectin
IS5231A (is) Vefjaþáttur sem hefur áhrif á blóðæðarmyndun
SE8802040D0 (sv) New use
ATE314851T1 (de) Synergistische wechselwirkung von abacavir und alovudin
SE9803271D0 (sv) A drug for well-being
MY136408A (en) Active substance combinations and therapies for treating abuse of alcohol